Published in
Elsevier, European Journal of Cancer, (110), p. 1-7, 2019
DOI: 10.1016/j.ejca.2018.12.026
Links
Tools
Monitoring evidence on overall survival benefits of anticancer drugs approved by the European Medicines Agency between 2009 and 2015
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 